Reducing Invasive Procedures Boosts Cardiovascular Diagnostics Market

NEW YORK - July 1, 2013 - PRLog -- The global cardiac diagnostics market totaled approximately $13.2 billion in 2012, increasing at a rate of 3.1% from $12.4 billion in 2010 according to Kalorama Information.    The healthcare market researcher said that growth will continue at a faster pace, growing at a rate of 5% for the next few years.   New technologies in testing will likely continue to fuel growth in combination with an aging population, increasing cardiovascular disease incidence and prevalence, and increasing life expectancy.  The finding was made in its new market research report, The World Market for Cardiovascular Diagnostics.

Economic conditions in several markets within the global cardiac diagnostics market remained challenging in 2012, but Kalorama report doesn’t see sluggish growth continuing.   Demand for cardiovascular diagnostics slowed during the historical period due to a weakened global economy, cost cutting measures and healthcare reform issues. However, demographics worldwide and an aging world society remain primary factors in growth.  By 2020, 16 percent of the US population will be over the age of 65, the report said.  

The report sees new procedures, such as cardiac marker tests and CT driving sales.  Computed tomography of the heart is not yet routinely used in clinical practice. It may be useful in the diagnosis of suspected coronary heart disease, for follow-up of a coronary artery bypass, for the evaluation of valvular heart disease and for the evaluation of cardiac masses. More than just a diagnostic tool to determine whether or not a patient has coronary artery disease, coronary CT angiography can help physicians predict a patient’s risk of future cardiac problems, according to a 2011 study published online in the Journal of the American College of Cardiology.

“At present, it appears that the greatest utility of cardiac CT lies in ruling out coronary artery disease rather than ruling it in.” said Mary Ann Crandall, author of the study.  “It’s unclear if it replaces catheterization, but it’s a factor.”

Cardiac markers are another growth area according to the report.  These biomarkers, usually enzymes, are measured to evaluate heart function.  Physicians use cardiac markers to diagnose a cardiac event in the hospital emergency room or to evaluate the risk of a cardiovascular event occurring.  The traditional markers are CK-MB, troponin, and myglobin.

The report, The World Market for Cardiovascular Diagnostics, describes several other cardiovascular testing markets and provides market estimates and forecasts by sector.  The report discusses the trends driving the industry in detail and profiles large companies in the sector.   The report can be obtained at Kalorama Information’s website at http://www.kaloramainformation.com/Cardiovascular-Diagnostics-7647668/.

About Kalorama Information

Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research (http://www.kaloramainformation.com/) in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter (http://www.twitter.com/KaloramaInfo), LinkedIn (http://www.linkedin.com/groups?gid=2177845&trk=hb_side_g) and our blog (http://www.kaloramakeypoint.blogspot.com/).